米国のニキビ治療パッチ市場規模、シェア、動向分析レポート：タイプ別、年齢層別、流通チャネル別、セグメント予測、2025-2033年

米国のニキビ治療パッチ市場動向：

米国のニキビ治療パッチ市場規模は2024年に1億3,360万米ドルと推定され、2025年から2033年にかけてCAGR 6.8%で成長すると予測されています。

米国で流行している糖尿病と肥満は、にきびを誘発するホルモンバランスの乱れに関連しており、にきび有病率の上昇に寄与し、抗にきび皮膚パッチの採用を増加させています。米国薬剤師によれば、米国のにきび対策市場が活況を呈している主な要因は、これらの製品の広範なマーケティング、自信と透明感のある肌の増加、およびそのような製品が複数入手可能であることです。

米国皮膚科学会によると、にきびは米国で最も一般的で流行している皮膚疾患であり、4,000万人から5,000万人が罹患しています。JAMA Dermatologyの調査によると、にきびは普遍的な皮膚病であり、米国のような西洋化社会では思春期の人口の79％から95％が罹患しており、にきびの有病率は年齢とともに増加します。また、米国では人口の85％が生涯のどこかで尋常性ざ瘡に罹患することが明らかになっています。

自然でオーガニックな製品への需要の高まりは、個人に合わせたスキンケアソリューションとともに、米国のニキビ治療パッチ業界を牽引することになると思われます。消費者は、持続可能性と皮膚の健康に対する価値観に沿った、環境に優しく化学物質を含まない選択肢をますます求めるようになっています。さらに、個々の肌タイプや悩みに合わせて製品をカスタマイズするパーソナライズドスキンケアの動向は、より効果的なソリューションを可能にし、顧客満足度を高めています。このような動向は、プレミアムでカスタマイズされたナチュラルな抗ニキビ製品へのシフトに寄与し、米国のニキビ治療パッチ産業の成長に拍車をかけています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 調査手法

• 情報調達
• データ分析

第4章 市場の変数、傾向、範囲

• 市場セグメンテーションと範囲
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国のニキビ治療パッチ市場-PESTLE分析
• 業界分析- ポーターのファイブフォース分析

第5章 米国のニキビ治療パッチ市場：タイプの推定・動向分析

• 米国のニキビ治療パッチ市場：タイプ分析
• 化学ベース
• ハーブベース

第6章 米国のニキビ治療パッチ市場：年齢層の推定・動向分析

• 米国のニキビ治療パッチ市場：年齢層分析
• 10～17歳
• 18歳～44歳
• 45～64歳
• 65歳以上

第7章 米国のニキビ治療パッチ市場：流通チャネルの推定・動向分析

• 米国のニキビ治療パッチ市場：流通チャネル分析
• 小売店
• 薬局・ドラッグストア
• Eコマースプラットフォーム

第8章 競合情勢

• 企業プロファイル
  • ZitSticka
  • 3M
  • Starface
  • Hero Cosmetics
  • Sephora USA, Inc.
  • Blackbird Skincare
  • Peach &Lily
  • Amparo Medical Technologies
  • Hi-Tech Products
  • Peace Out Skincare

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity Flow Analysis
• Fig. 7 Anti-Acne Dermal Patch market snapshot (2024)
• Fig. 8 Parent market outlook
• Fig. 9 Ancillary market outlook
• Fig. 10 Anti-Acne Dermal Patch market segmentation
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Porter's five forces analysis
• Fig. 14 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 15 Anti-Acne Dermal Patch market Type outlook: Segment dashboard
• Fig. 16 Anti-Acne Dermal Patch market: Type movement analysis
• Fig. 17 Chemical-based market, 2021 - 2033 (USD Million)
• Fig. 18 Herbal-based market, 2021 - 2033 (USD Million)
• Fig. 19 Anti-Acne Dermal Patch market Age Group outlook: Segment dashboard
• Fig. 20 Anti-Acne Dermal Patch market: Age Group movement analysis
• Fig. 21 10 to 17 market, 2021 - 2033 (USD Million)
• Fig. 22 18 to 44 market, 2021 - 2033 (USD Million)
• Fig. 23 45 to 64 market, 2021 - 2033 (USD Million)
• Fig. 24 65+ market: 2021 - 2033 (USD Million)
• Fig. 25 Anti-Acne Dermal Patch market Distribution Channel outlook: Segment dashboard
• Fig. 26 Anti-Acne Dermal Patch market: Distribution Channel movement analysis
• Fig. 27 Retail Stores market, 2021 - 2033 (USD Million)
• Fig. 28 Pharmacies & Drug Stores market, 2021 - 2033 (USD Million)
• Fig. 29 E-Commerce Platform market, 2021 - 2033 (USD Million)

U.S. Anti-acne Dermal Patch Market Trends:

The U.S. anti-acne dermal patch market size was estimated at USD 133.6 million in 2024 and is expected to grow at a CAGR of 6.8% from 2025 to 2033. Diabetes and obesity, which remain at epidemic levels in the U.S., are linked to hormonal imbalances that can trigger acne, thereby contributing to the rising prevalence of acne and increasing the adoption of anti-acne dermal patches. According to the U.S. Pharmacist, major components of the booming U.S. anti-acne market are the extensive marketing of these products, implications of increased self-confidence & clearer skin, and availability of several such products.

According to the American Academy of Dermatology, acne is the most common and prevalent skin condition in the U.S., affecting between 40 million and 50 million individuals. As per a study conducted by JAMA Dermatology, acne is a universal skin disease, affecting 79% to 95% of the adolescent population in westernized societies such as the U.S., and the prevalence of acne increases with age. It also revealed that up to 85% of the U.S. population will be affected by acne vulgaris at some point in their lives.

The growing demand for natural and organic products, along with personalized skincare solutions, is set to drive the U.S. anti-acne dermal patch industry. Consumers are increasingly seeking eco-friendly, chemical-free options that align with sustainability and skin health values. Furthermore, the growing trend of personalized skincare-where products are tailored to individual skin types and concerns-enables more effective solutions, enhancing customer satisfaction. These trends contribute to a shift toward premium, customized, natural anti-acne products, fueling the growth of the U.S. anti-acne derma patch industry.

U.S. Anti-acne Dermal Patch Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. anti-acne dermal patch market report based on type, age group, and distribution channel:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Chemical-based
• Herbal-based
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• 10 to 17
• 18 to 44
• 45 to 64
• 65+
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail Stores
• Pharmacies & Drug Stores
• E-commerce Platform

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market segmentation & scope
• 1.2. Information procurement
  • 1.2.1. Purchased database
  • 1.2.2. GVR's internal database
  • 1.2.3. Secondary sources & third-party perspectives
  • 1.2.4. Primary research
• 1.3. Information analysis
  • 1.3.1. Data analysis models
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot

Chapter 3. Research Methodology

• 3.1. Information Procurement
• 3.2. Data Analysis

Chapter 4. Market Variables, Trends& Scope

• 4.1. Market Segmentation and Scope
  • 4.1.1. Market driver analysis
  • 4.1.2. Market restraint analysis
• 4.2. U.S. anti-acne dermal patch market - PESTLE Analysis
• 4.3. Industry Analysis - Porter's

Chapter 5. U.S. anti-acne dermal patch market: Type Estimates & Trend Analysis

• 5.1. U.S. anti-acne dermal patch market: Type Analysis
• 5.2. Chemical-based
  • 5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
• 5.3. Herbal-based
  • 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. U.S. anti-acne dermal patch market: Age Group Estimates & Trend Analysis

• 6.1. U.S. anti-acne dermal patch market: Age Group Analysis
• 6.2. 10 to 17
  • 6.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.3. 18 to 44
  • 6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.4. 45 to 64
  • 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.5. 65+
  • 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. U.S. anti-acne dermal patch market: Distribution Channel Estimates & Trend Analysis

• 7.1. U.S. anti-acne dermal patch market: Distribution Channel Analysis
• 7.2. Retail Stores
  • 7.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
• 7.3. Pharmacies & Drug Stores
  • 7.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
• 7.4. E-Commerce Platform
  • 7.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Profiles
  • 8.1.1. ZitSticka
    • 8.1.1.1. Company overview
    • 8.1.1.2. Financial performance
    • 8.1.1.3. Product benchmarking
    • 8.1.1.4. Strategic initiatives
  • 8.1.2. 3M
    • 8.1.2.1. Company overview
    • 8.1.2.2. Financial performance
    • 8.1.2.3. Product benchmarking
    • 8.1.2.4. Strategic initiatives
  • 8.1.3. Starface
    • 8.1.3.1. Company overview
    • 8.1.3.2. Financial performance
    • 8.1.3.3. Product benchmarking
    • 8.1.3.4. Strategic initiatives
  • 8.1.4. Hero Cosmetics
    • 8.1.4.1. Company overview
    • 8.1.4.2. Financial performance
    • 8.1.4.3. Product benchmarking
    • 8.1.4.4. Strategic initiatives
  • 8.1.5. Sephora USA, Inc.
    • 8.1.5.1. Company overview
    • 8.1.5.2. Financial performance
    • 8.1.5.3. Product benchmarking
    • 8.1.5.4. Strategic initiatives
  • 8.1.6. Blackbird Skincare
    • 8.1.6.1. Company overview
    • 8.1.6.2. Financial performance
    • 8.1.6.3. Product benchmarking
    • 8.1.6.4. Strategic initiatives
  • 8.1.7. Peach & Lily
    • 8.1.7.1. Company overview
    • 8.1.7.2. Financial performance
    • 8.1.7.3. Product benchmarking
    • 8.1.7.4. Strategic initiatives
  • 8.1.8. Amparo Medical Technologies
    • 8.1.8.1. Company overview
    • 8.1.8.2. Financial performance
    • 8.1.8.3. Product benchmarking
    • 8.1.8.4. Strategic initiatives
  • 8.1.9. Hi-Tech Products
    • 8.1.9.1. Company overview
    • 8.1.9.2. Financial performance
    • 8.1.9.3. Product benchmarking
    • 8.1.9.4. Strategic initiatives
  • 8.1.10. Peace Out Skincare
    • 8.1.10.1. Company overview
    • 8.1.10.2. Financial performance
    • 8.1.10.3. Product benchmarking
    • 8.1.10.4. Strategic initiatives